Mar 12 2015 Relmada Therapeutics to Present at Future Leaders in the Biotech Industry Conference View
Mar 05 2015 Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles View
Mar 03 2015 Relmada Therapeutics to Present at ROTH Capital Partners 27th Annual Growth Stock Conference View
Feb 24 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Novel Oral Formulations of Buprenorphine View
Jan 16 2015 Relmada Therapeutics to Present at 11th Annual Noble Financial Capital Markets Equity Conference View
Jan 13 2015 Relmada Therapeutics Reaches Midway Point in Dose Escalation for Phase One Study of Novel NMDA Receptor Antagonist d-Methadone View
